Skip to Main Content
Table 1. 
Participant characteristics.
VariableASD Mean ± SD [range]TD Mean ± SD [range]Significance
N 145 121   
Age 16.47 ± 6.46 [7.13–39.10] 16.03 ± 5.70 [6.47–31.78] t(264) = 0.58, p = 0.56 
IQ 107.57 ± 16.32 [76–148] 110.08 ± 11.61 [80–133] t(264) = −1.43, p = 0.15 
Mean FD 0.07 ± 0.04 [0.02–0.19] 0.07 ± 0.03 [0.03–0.19] t(264) = 1.32, p = 0.19 
Percent FD > 0.2 mm 4.69 ± 5.27 [0–19.33] 3.92 ± 1.29 [0–19.33] t(264) = 1.29, p = 0.20 
Handedness 120 RH 21 LH 109 RH 10 LH X2(1, N = 266) = 0.52, p = 0.13 
Eye status 121 open 24 closed 95 open 26 closed X2(1, N = 266) = 1.38, p = 0.35 
Scan site NYU: 59 SDSU: 11 TRINITY: 18 UM: 26 USM: 31 NYU: 52 SDSU: 10 TRINITY: 16 UM: 29 USM: 14 X2(4, N = 266) = 5.07, p = 0.28 
Medication use 27 yes 86 no 32 unknown 0 yes 106 no 15 unknown N/A 
Comorbidities 28 yes 117 no/unknown 0 yes 121 no/unknown N/A 
ADOS Total 11.69 ± 3.68 [5–22] (N = 118) 1.14 ± 1.17 [0–4] (N = 14) t(130) = 10.64, p < 0.001 
ADOS Communication 3.89 ± 1.55 [0–8] (N = 100) 0.50 ± 0.65 [0–2] (N = 14) t(112) = 8.06, p < 0.001 
ADOS Social 7.89 ± 2.81 [2–14] (N = 100) 0.64 ± 0.84 [0–3] (N = 14) t(112) = 9.56, p < 0.001 
ADOS RRB 2.04 ± 1.46 [0–7] (N = 98) 0.07 ± 0.27 [0–1] (N = 14) t(110) = 5.00, p < 0.001 
ADI-R Social 19.07 ± 5.44 [7–30] (N = 108) N/A N/A 
ADI-R Verbal 15.38 ± 4.36 [2–25] (N = 109) N/A N/A 
ADI-R RRB 5.66 ± 2.60 [0–12] (N = 109) N/A N/A 
SRS 92.56 ± 31.00 [26–164] (N = 89) 20.59 ± 12.43 [1–56] (N = 49) t(136) = 15.56, p < 0.001 
VariableASD Mean ± SD [range]TD Mean ± SD [range]Significance
N 145 121   
Age 16.47 ± 6.46 [7.13–39.10] 16.03 ± 5.70 [6.47–31.78] t(264) = 0.58, p = 0.56 
IQ 107.57 ± 16.32 [76–148] 110.08 ± 11.61 [80–133] t(264) = −1.43, p = 0.15 
Mean FD 0.07 ± 0.04 [0.02–0.19] 0.07 ± 0.03 [0.03–0.19] t(264) = 1.32, p = 0.19 
Percent FD > 0.2 mm 4.69 ± 5.27 [0–19.33] 3.92 ± 1.29 [0–19.33] t(264) = 1.29, p = 0.20 
Handedness 120 RH 21 LH 109 RH 10 LH X2(1, N = 266) = 0.52, p = 0.13 
Eye status 121 open 24 closed 95 open 26 closed X2(1, N = 266) = 1.38, p = 0.35 
Scan site NYU: 59 SDSU: 11 TRINITY: 18 UM: 26 USM: 31 NYU: 52 SDSU: 10 TRINITY: 16 UM: 29 USM: 14 X2(4, N = 266) = 5.07, p = 0.28 
Medication use 27 yes 86 no 32 unknown 0 yes 106 no 15 unknown N/A 
Comorbidities 28 yes 117 no/unknown 0 yes 121 no/unknown N/A 
ADOS Total 11.69 ± 3.68 [5–22] (N = 118) 1.14 ± 1.17 [0–4] (N = 14) t(130) = 10.64, p < 0.001 
ADOS Communication 3.89 ± 1.55 [0–8] (N = 100) 0.50 ± 0.65 [0–2] (N = 14) t(112) = 8.06, p < 0.001 
ADOS Social 7.89 ± 2.81 [2–14] (N = 100) 0.64 ± 0.84 [0–3] (N = 14) t(112) = 9.56, p < 0.001 
ADOS RRB 2.04 ± 1.46 [0–7] (N = 98) 0.07 ± 0.27 [0–1] (N = 14) t(110) = 5.00, p < 0.001 
ADI-R Social 19.07 ± 5.44 [7–30] (N = 108) N/A N/A 
ADI-R Verbal 15.38 ± 4.36 [2–25] (N = 109) N/A N/A 
ADI-R RRB 5.66 ± 2.60 [0–12] (N = 109) N/A N/A 
SRS 92.56 ± 31.00 [26–164] (N = 89) 20.59 ± 12.43 [1–56] (N = 49) t(136) = 15.56, p < 0.001 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept